Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 7/2020

20-02-2020

Predictors of health-related quality of life among military HIV-infected individuals

Auteurs: Leonard Emuren, Seth Welles, Grace Macalino, Alison A. Evans, Marcia Polansky, Anuradha Ganesan, Rhonda E. Colombo, Brian K. Agan, the Infectious Disease Clinical Research Program HIV Working Group

Gepubliceerd in: Quality of Life Research | Uitgave 7/2020

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Objectives

To determine long-term predictors of health-related quality of life (HRQOL) and evaluate the treatment effect of highly active antiretroviral therapy (HAART) on HRQOL in the US Military HIV Natural History Study (NHS) cohort.

Methods

Participants were a nested cohort of the NHS who responded to the Rand Short Form 36 questionnaire administered from 2006 to 2010. Physical component summary scores (PCS) and mental component summary scores (MCS) were computed using standard algorithms. HAART-status was categorized as non-protease inhibitor-based (NPI-HAART), protease inhibitor-based (PI-HAART), HAART-naïve, or off-HAART. Mixed linear random effects models were used to estimate changes in PCS and MCS over time for treatment and covariates (including CD4 count, HIV viral load, medical and mental comorbidities).

Results

Eight hundred and twelve participants met the inclusion criteria. There was no difference in PCS or MCS between those on PI-HAART compared to NPI-HAART. Significant predictors of PCS were CD4 count < 200 cells/mm3 (β = − 2.90), CD4 count 200–499 cells/mm3 (β = − 0.80), and mental comorbidity (β = − 3.23). Others were medical comorbidity, AIDS-defining illness, being on NPI-HAART, HAART-naïve, age, and rank. Those with medical comorbidities experienced yearly improvement in PCS. Predictors of MCS were CD4 count < 200 cells/mm3 (β = − 2.53), mental comorbidity (β = − 4.58), and being African American (β = 2.59).

Conclusion

HRQOL was significantly affected by low CD4 count, medical and mental comorbidities. Addressing these modifiable factors would be expected to improve the physical and mental HRQOL of the cohort. Our study did not find any treatment benefit of NPI-HAART over PI-HAART on HRQOL in the long term.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Wenger, N., & Furberg, C. (1990). Cardiovascular disorders. Quality of life assessment in clinical trials (pp. 335–345). New York: Raven Press. Wenger, N., & Furberg, C. (1990). Cardiovascular disorders. Quality of life assessment in clinical trials (pp. 335–345). New York: Raven Press.
9.
go back to reference Fumaz, C. R., Tuldra, A., Ferrer, M. J., Paredes, R., Bonjoch, A., Jou, T., et al. (2002). Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens. Journal of Acquired Immune Deficiency Syndromes, 29(3), 244–253. CrossRef Fumaz, C. R., Tuldra, A., Ferrer, M. J., Paredes, R., Bonjoch, A., Jou, T., et al. (2002). Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens. Journal of Acquired Immune Deficiency Syndromes, 29(3), 244–253. CrossRef
20.
go back to reference Hopman, W. M., Berger, C., Joseph, L., Towheed, T., Prior, J. C., Anastassiades, T., et al. (2009). Health-related quality of life in Canadian adolescents and young adults: Normative data using the SF-36. Canadian Journal of Public Health, 100(6), 449–452. CrossRef Hopman, W. M., Berger, C., Joseph, L., Towheed, T., Prior, J. C., Anastassiades, T., et al. (2009). Health-related quality of life in Canadian adolescents and young adults: Normative data using the SF-36. Canadian Journal of Public Health, 100(6), 449–452. CrossRef
21.
go back to reference Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011). Applied longitudinal analysis (Second ed., Wiley Series in Probability and Statistics). New Jersey: Wiley. CrossRef Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011). Applied longitudinal analysis (Second ed., Wiley Series in Probability and Statistics). New Jersey: Wiley. CrossRef
28.
go back to reference Campo, R. E., Cohen, C., Grimm, K., Shangguan, T., Maa, J., & Seekins, D. (2010). Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients. International Journal of STD and AIDS, 21(3), 166–171. https://​doi.​org/​10.​1258/​ijsa.​2009.​008487. CrossRefPubMed Campo, R. E., Cohen, C., Grimm, K., Shangguan, T., Maa, J., & Seekins, D. (2010). Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients. International Journal of STD and AIDS, 21(3), 166–171. https://​doi.​org/​10.​1258/​ijsa.​2009.​008487. CrossRefPubMed
29.
go back to reference Crum-Cianflone, N. F., Grandits, G., Echols, S., Ganesan, A., Landrum, M., Weintrob, A., et al. (2010). Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? Journal of Acquired Immune Deficiency Syndromes, 54(3), 248–257. CrossRef Crum-Cianflone, N. F., Grandits, G., Echols, S., Ganesan, A., Landrum, M., Weintrob, A., et al. (2010). Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? Journal of Acquired Immune Deficiency Syndromes, 54(3), 248–257. CrossRef
30.
go back to reference Pogany, K., van Valkengoed, I. G., Prins, J. M., Nieuwkerk, P. T., van der Ende, I., Kauffmann, R. H., et al. (2007). Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN). Journal of Acquired Immune Deficiency Syndromes, 44(4), 395–400. https://​doi.​org/​10.​1097/​QAI.​0b013e31802f83bc​. CrossRefPubMed Pogany, K., van Valkengoed, I. G., Prins, J. M., Nieuwkerk, P. T., van der Ende, I., Kauffmann, R. H., et al. (2007). Effects of active treatment discontinuation in patients with a CD4+ T-cell nadir greater than 350 cells/mm3: 48-week Treatment Interruption in Early Starters Netherlands Study (TRIESTAN). Journal of Acquired Immune Deficiency Syndromes, 44(4), 395–400. https://​doi.​org/​10.​1097/​QAI.​0b013e31802f83bc​. CrossRefPubMed
33.
go back to reference Walker, A. M. (1996). Confounding by indication. Epidemiology, 7(4), 335–336. PubMed Walker, A. M. (1996). Confounding by indication. Epidemiology, 7(4), 335–336. PubMed
Metagegevens
Titel
Predictors of health-related quality of life among military HIV-infected individuals
Auteurs
Leonard Emuren
Seth Welles
Grace Macalino
Alison A. Evans
Marcia Polansky
Anuradha Ganesan
Rhonda E. Colombo
Brian K. Agan
the Infectious Disease Clinical Research Program HIV Working Group
Publicatiedatum
20-02-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2020
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02441-5